Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00218465
Status:
COMPLETED
Last Update Posted:
2017-03-24
First Post:
2005-09-16
Brief Title:
Effectiveness of GW468816 an NMDA Glycine Site Antagonist for Prevention of Relapse to Smoking
Sponsor:
Massachusetts General Hospital
Organization:
Massachusetts General Hospital
Organization Data
Organization:
Massachusetts General Hospital
Class:
OTHER
Study ID:
NIDA-19378-2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Massachusetts General Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Maurizio Fava MD
Responsible Party Title:
Maurizio Fava MD
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Massachusetts General Hospital
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| GlaxoSmithKline | INDUSTRY |
| National Institute on Drug Abuse NIDA | NIH |
| Mclean Hospital | OTHER |